SCHEMBL26803154

SCHEMBL26803154

CO[C@@H](C)Cn1cnc(F)c1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26793375 1.00 BRD4 (0.33) BRD4
SCHEMBL26793377 0.84 BRD4 (0.32) BRD4
SCHEMBL26793514 0.82 BRD4 (0.33) BRD4
SCHEMBL26660697 0.78 BRD4 (0.40) BRD4
SCHEMBL26660693 0.78 BRD4 (0.40) BRD4
SCHEMBL26793353 0.70 BRD4 (0.37) BRD4
SCHEMBL24845644 0.70
SCHEMBL31252138 0.66 BRD4 (0.41) BRD4
SCHEMBL26838403 0.64 FDPS (0.46)
SCHEMBL26803149 0.64 FDPS (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230609-A1 HETEROCYCLIC PAD4 INHIBITORS CELGENE CORPORATION (US) 2023-11-30 WO disclosed
WO-2023230612-A1 HETEROCYCLIC PAD4 INHIBITORS CELGENE CORPORATION (US) 2023-11-30 WO disclosed